A Promising New Strategy to Improve Treatment Outcomes for Patients with Depression

Area of Science:

• Neuroscience
• Psychiatry
• Medical Informatics

Background:

• Ineffective management of mental illness impacts individuals and society.
• A lack of objective markers for predicting drug response leads to "trial and error" prescribing in behavioral health.
• Clinicians seek objective data, like laboratory or imaging tests, to guide treatment selection.

Purpose of the Study:

• To evaluate the utility of Electroencephalogram (EEG) findings combined with medication outcomes data in predicting patient response to psychiatric medications.
• To assess the effectiveness of the Psychiatric EEG Evaluation Registry (PEER) database in providing objective markers for treatment selection.

Main Methods:

• Utilized a "crowdsourced" physician registry approach, similar to cancer treatment strategies.
• Leveraged the Psychiatric EEG Evaluation Registry (PEER), a clinical phenotypic database containing over 11,000 baseline EEGs and 39,000 medication treatment outcomes.
• Analyzed data from 45 studies involving 3130 patients.

Main Results:

• Collective findings provide compelling evidence for EEG as a predictor of patient response to specific antidepressants.
• EEG findings, within the PEER database, can predict likely treatment-related side effects, including suicidal ideation.
• PEER demonstrates a simple, inexpensive method for predicting medication response in mental health.

Conclusions:

• Electroencephalogram (EEG) biomarkers, as utilized in the PEER database, offer a viable solution to "trial and error" prescribing in mental health.
• Objective EEG data can significantly improve the medical management of patients with mental illness.
• The PEER approach represents a promising advancement in personalized psychiatric care, enhancing patient well-being and health outcomes.